Vibration Training for Preventing Falls in Healthy Population and Multiple Sclerosis
NCT ID: NCT02694666
Last Updated: 2023-11-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
58 participants
INTERVENTIONAL
2016-04-30
2023-04-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comprehensive Fall Prevention and Detection in Multiple Sclerosis
NCT02583386
Effects of 3 Months of Controlled Whole Body Vibrations on the Risk of Falls Among Nursing Home Residents
NCT01759680
Comparison of Two Community Based Exercise Protocols in People With Multiple Sclerosis
NCT03429062
Fall Risk Reduction in Multiple Sclerosis: Exercise Versus Behavior
NCT01956227
Fall Risk Reduction in Multiple Sclerosis (FIRMS)
NCT02314585
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vibration training group
The vibration group will receive 8-week controlled whole-body vibration training as the intervention on the Galileo Med L device
Controlled whole-body vibration training
The intervention is an 8-week program
Placebo training group
The placebo group will receive 8-week placebo training on the Galileo Med L device
Controlled whole-body vibration training
The intervention is an 8-week program
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Controlled whole-body vibration training
The intervention is an 8-week program
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged between 18 and 75
* No known history of musculoskeletal, neurological, cardiovascular, or pulmonary impairment
For people with multiple sclerosis
* Self-reported multiple sclerosis and confirmed by the physician
* No significant relapse within the past 8 weeks
* To be able to walk independently a length of 25 feet
* Score on Patient Determined Disease Step \< 7
Exclusion Criteria
* The heel bone density is less than -2.0
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Georgia State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Feng Yang, PhD
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Feng Yang, PhD
Role: PRINCIPAL_INVESTIGATOR
Georgia State University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Georgia State University
Atlanta, Georgia, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Yang F, Su X, Sanchez MC, Hackney ME, Butler AJ. Vibration training reducing falls in community-living older adults: a pilot randomized controlled trial. Aging Clin Exp Res. 2023 Apr;35(4):803-814. doi: 10.1007/s40520-023-02362-6. Epub 2023 Feb 13.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
514810
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.